国家卫生健康委:国家组织药品集中采购试点实施效果总体好于预期

2019-05-04 车丽 央广网

国家卫生健康委和国家医保局表示,国家组织药品集中采购试点实施效果总体上好于预期,中选药品质量平稳、供应充足,明显减轻了患者负担。国家组织药品集中采购试点4月1日在11个城市全部启动,截止4月14日24点,25个中选品种在11个试点地区采购总数量达4.38亿片/支,总金额为5.33亿元,约定采购量完成进度达27.31%,大幅降低了患者药品费用负担,以中选的乙肝抗病毒仿制药恩替卡韦分散片为例,年用药费

国家卫生健康委和国家医保局表示,国家组织药品集中采购试点实施效果总体上好于预期,中选药品质量平稳、供应充足,明显减轻了患者负担。

国家组织药品集中采购试点4月1日在11个城市全部启动,截止4月14日24点,25个中选品种在11个试点地区采购总数量达4.38亿片/支,总金额为5.33亿元,约定采购量完成进度达27.31%,大幅降低了患者药品费用负担,以中选的乙肝抗病毒仿制药恩替卡韦分散片为例,年用药费用将由9000元左右降至200元左右。

国家医保局副局长陈金甫:扎实做好试点组织实施,加强试点情况监测和指导,做好试点地区中选药品的质量和供应保障,促进中选药品优先使用,让患者充分享受改革的红利。优化完善药品集中采购制度,研究部署扩大试点工作。

国家卫生健康委体制改革司副司长薛海宁表示,我国将进一步完善推动落实国家基本药物制度,研究推进国家基本药物供应保障的综合试点,建立优先使用激励机制,促进上下级医疗机构之间的用药衔接。同时以国家组织药品集中采购试点作为一个突破口,推动医改在重点领域和关键环节取得新的进展。

薛海宁:加快药品信息化追溯体系的建设,率先实现疫苗、特殊药品和国家集中采购药品“一物一码,物码同追”,做好短缺药品供应保障,药品流通体制的改革,促进合理用药、规范用耗材使用,加强药品质量安全监管等等一系列的工作,满足群众不断增长的医疗卫生健康服务需求。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
    2019-05-06 wolongzxh
  8. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1694319, encodeId=852c169431954, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Thu Mar 26 07:35:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770586, encodeId=43971e70586e5, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sat Aug 24 21:35:00 CST 2019, time=2019-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641719, encodeId=55661641e1977, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Fri Jul 26 14:35:00 CST 2019, time=2019-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458018, encodeId=44dc1458018b1, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460124, encodeId=0b8f14601244b, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492956, encodeId=017f14929569e, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532856, encodeId=21ff153285622, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568106, encodeId=37bb15681061d, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Mon May 06 11:35:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1046812, encodeId=641410468120e, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat May 04 23:35:00 CST 2019, time=2019-05-04, status=1, ipAttribution=)]
    2019-05-04 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

重磅!国家卫生健康委允许体细胞治疗进入临床应用

三年前,“细胞疗法”因一起不良事件被公众知晓。此后原国家卫生计生委发文叫停,明确要求自体免疫细胞治疗技术按“临床研究”规定执行。现在,细胞治疗临床研究和应用又出新规。3月29日,国家卫生健康委公布《体细胞治疗临床研究和转化应用管理办法(试行)(征求意见稿)》(下称《意见稿》),明确对体细胞临床研究进行备案管理,允许经医疗机构临床研究证明安全有效的体细胞治疗项目经备案后在本医疗机构进入转化应用。什么

建议把手术签字权还给患者本人?国家卫生健康委回应

榆林产妇因不堪分娩痛苦坠楼身亡一事,过去已经一年多。这一事件也引起了全国人大代表、哈尔滨医科大学附属第二医院院长张斌的关注。他在2018年的全国两会上提交了一份建议,建议全国人大常委会启动国务院《医疗机构管理条例》的合法性审查,规范患者医疗签字方式,明确患者医疗签字的自主权。对此,南都记者注意到,国家卫健委在近日公开的一份答复中表示, 将积极配合全国人大常委会法工委开展相关法律法规修订工作,结合该

预见!2019年,国家卫生健康委将有这些动作

进入2019年,卫生健康十项重点工作被医疗圈所关注和讨论。在大健康环境下,以“治病为中心”转变为“以人民健康为中心”,无疑仍是2019年卫生健康行业的主旨。

浙江长兴为何能吸引国家卫生健康委三次调研?

县级公立医院是我国医疗体系建设中的枢纽,其承上启下的作用,时刻影响着医改的整体水平。太湖,我国五大淡水湖之一,承接着周边50余条主要河道的汇入与流出。地处太湖西南岸的浙江省湖州市长兴县人民医院,作为县域医共体集团牵头单位,同样承接着对上、对下的医疗联动。上可通过与浙江大学医学院附属第二医院(下称浙医二院)合作让自身强壮起来,下可与8家乡镇卫生院(社区卫生服务中心)紧密配合向63万人口输出资源。

2020年实现健康教育全覆盖

11月12日,国家卫生健康委召开例行新闻发布会,介绍《贫困地区健康促进三年攻坚行动方案》及贫困地区健康促进工作开展有关情况。《方案》明确,到2020年,实现贫困地区居民健康教育全覆盖;省、地市、县各级建成健康教育骨干队伍并实现培训全覆盖;以县区为单位,50%的中小学校达到健康促进学校标准。

公立医院改革下一步如何做?国家卫生健康委和发改委说话了

公立医院改革目前遇到了哪些突出的重要问题?下一步还想采取哪些步骤和做法?在鼓励社会力量办医方面,政府有什么打算?这些问题,国家卫生健康委和发改委都做了回答。近日,十三届全国人大常委会第七次会议在人民大会堂举行联组会议,围绕审议国务院关于财政医疗卫生资金分配和使用情况的报告开展专题询问。公立医院改革有哪些措施?有什么困难?下一步怎么干?这些社会普遍关注的问题被全国人大常委会委员一一提出。这些问题,卫